BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26068763)

  • 1. Molecular Pathology of Soft-Tissue Neoplasms and Its Role in Clinical Practice.
    Henderson-Jackson EB; Bui MM
    Cancer Control; 2015 Apr; 22(2):186-92. PubMed ID: 26068763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular pathology of soft tissue tumors: Contribution to diagnosis and therapy prediction].
    Schmitz K; Schildhaus HU
    Pathologe; 2015 Mar; 36(2):126-36. PubMed ID: 25822596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
    Genevay M; Gengler C; Guillou L
    Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphology, molecular genetics and multidisciplinary management: soft tissue pathology in 2014 and beyond.
    Hemmings C
    Pathology; 2014 Feb; 46(2):93-4. PubMed ID: 24378394
    [No Abstract]   [Full Text] [Related]  

  • 5. The Recent Advances in Molecular Diagnosis of Soft Tissue Tumors.
    Choi JH; Ro JY
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pathology of soft tissue sarcomas].
    Schmidt D
    Radiologe; 1992 Dec; 32(12):579-83. PubMed ID: 1492148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soft tissue sarcoma: from molecular diagnosis to selection of treatment. Pathological diagnosis of soft tissue sarcoma amid molecular biology and targeted therapies.
    Wardelmann E; Schildhaus HU; Merkelbach-Bruse S; Hartmann W; Reichardt P; Hohenberger P; Büttner R
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii265-9. PubMed ID: 20943625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications.
    Marino-Enriquez A
    Surg Pathol Clin; 2015 Sep; 8(3):525-37. PubMed ID: 26297069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytogenetic and molecular characterization of benign and malignant soft tissue tumors.
    Sreekantaiah C
    Cytogenet Cell Genet; 1998; 82(1-2):13-29. PubMed ID: 9763652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
    Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
    Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular biology for sarcoma: useful or necessary?].
    Neuville A; Coindre JM; Chibon F
    Ann Pathol; 2015 Jan; 35(1):107-13. PubMed ID: 25533919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical role of molecular genetics in soft tissue tumor pathology.
    Busam KJ; Fletcher CD
    Cancer Metastasis Rev; 1997 Jun; 16(1-2):207-27. PubMed ID: 9156287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors.
    Bridge JA
    Mod Pathol; 2014 Jan; 27 Suppl 1():S80-97. PubMed ID: 24384855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.
    Mariño-Enríquez A; Bovée JV
    Surg Pathol Clin; 2016 Sep; 9(3):457-73. PubMed ID: 27523972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Molecular and Immunohistochemical Adjunct Modalities in the Diagnosis of Soft Tissue Neoplasms.
    Mourtzoukou D; Fisher C; Thway K
    Int J Surg Pathol; 2015 Dec; 23(8):601-8. PubMed ID: 26310271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary value of molecular analysis to expert review in refining classification of uncommon soft tissue tumors.
    Suurmeijer AJH; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23196. PubMed ID: 37702439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.
    Noujaim J; Thway K; Sheri A; Keller C; Jones RL
    Int J Surg Pathol; 2016 Feb; 24(1):5-15. PubMed ID: 26399578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New biological prognostic factors of soft tissue sarcoma. SFOP (Société française d'oncologie pédiatrique)].
    Delattre O; Michon J; Peter M; Oberlin O
    Cancer Radiother; 1997; 1(5):448-52. PubMed ID: 9587375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of soft tissue tumors.
    van de Rijn M; Fletcher JA
    Annu Rev Pathol; 2006; 1():435-66. PubMed ID: 18039122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment].
    Yamaguchi U; Hasegawa T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1340-5. PubMed ID: 15446553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.